Formulation of Effervescent Granules Based on <i>Calotropis procera</i> Ait Powder (Apocynaceae) and <i>Zanthoxylum zanthoxyloides</i> Lam (Rutaceae)

Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of <i>Zanthoxylum zanthoxyloides</i> and <i>Calotropis procera</i>. This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Science and Technology
Published
2025-05-14
DOI
https://doi.org/10.11648/j.pst.20250901.13
Primary Topic
Phytochemistry and Bioactive Compounds
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formulation of Effervescent Granules Based on <i>Calotropis procera</i> Ait Powder (Apocynaceae) and <i>Zanthoxylum zanthoxyloides</i> Lam (Rutaceae)

Salfo OUEDRAOGO, Rasmané Semdé, Tata Kadiatou Traoré, Sylvin Ouédraogo et al.
Pharmaceutical Science and Technology
Phytochemistry and Bioactive Compounds
article

Formulation of Effervescent Granules Based on <i>Calotropis procera</i> Ait Powder (Apocynaceae) and <i>Zanthoxylum zanthoxyloides</i> Lam (Rutaceae)

Salfo OUEDRAOGO, Rasmané Semdé, Tata Kadiatou Traoré, Sylvin Ouédraogo, Bertrand W. F. Goumbri, Rainer de Martin, Atchadé Constantin, Traoré Safiatou, Yaméogo Josias
article en

Abstract

Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of <i>Zanthoxylum zanthoxyloides</i> and <i>Calotropis procera</i>. This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.

Pharmaceutical Science and TechnologyVol. 9(1)
Université Joseph Ki-Zerbo (BF), Centre National de la Recherche Scientifique et Technologique (BF), Institut de Recherche en Sciences de la Santé (BF)
Openalex Percentile: Top 93%
Phytochemistry and Bioactive Compounds
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.